ArticleScientific reports2025
First comprehensive compositional analysis of E. arborescens leaves with new insights into their potential as enzyme inhibitors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This work aims to determine the chemical composition of E. arborescens leaves for the first time, screening and quantifying various phytochemical compounds. The chemical composition revealed high levels of valuable nutrients, mainly ash (19.32%), which increases its nutritional value and offers health benefits. The phytochemical screening identified numerous secondary metabolites, including phenolic compounds, phytosterols, and flavonoids. Quantification of photosynthetic pigments showed that chlorophyll a is dominant in the leaves. In addition, the methanolic extract of the leaves has inhibitory activity against gram-positive and gram-negative bacteria. The methanolic leaf extract showed an IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.